Integrating neuroimaging biomarkers into the multicentre, high-dose erythropoietin for asphyxia and encephalopathy (HEAL) trial: rationale, protocol and harmonisation

MLA

Taeun Chang, et al. “Integrating Neuroimaging Biomarkers into the Multicentre, High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) Trial: Rationale, Protocol and Harmonisation.” BMJ Open, vol. 11, no. 4, Apr. 2021. EBSCOhost, https://doi.org/10.1136/bmjopen-2020-043852.

APA

Taeun Chang, Brenda Poindexter, Gregory M. Sokol, Patrick J Heagerty, Mark Smith, Jessica L Wisnowski, Amit M Mathur, Jeffrey Berman, Ping-Sun Keven Chen, James Dix, Trevor Flynn, Stanley Fricke, Seth D Friedman, Hayden W Head, Chang Y Ho, Beth Kline-Fath, Michael Oveson, Richard Patterson, Sumit Pruthi, … Toby Yanowitz. (2021). Integrating neuroimaging biomarkers into the multicentre, high-dose erythropoietin for asphyxia and encephalopathy (HEAL) trial: rationale, protocol and harmonisation. BMJ Open, 11(4). https://doi.org/10.1136/bmjopen-2020-043852

Chicago

Taeun Chang, Brenda Poindexter, Gregory M. Sokol, Patrick J Heagerty, Mark Smith, Jessica L Wisnowski, Amit M Mathur, et al. 2021. “Integrating Neuroimaging Biomarkers into the Multicentre, High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) Trial: Rationale, Protocol and Harmonisation.” BMJ Open 11 (4). doi:10.1136/bmjopen-2020-043852.